Cases 1 - 10 of 138
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals Inc. et al
as 1:2024cv00428
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Teva Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al
as 1:2023cv01449
Plaintiff:
Novartis Pharmaceuticals Corporation, Novartis Pharma AG and Japan Tobacco Inc.
Defendant:
Novugen Oncology Sdn. Bhd., Novugen Pharma (USA) LLC and Makro Technologies, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Third Party Subpoenas Ad Testificandum
as 1:2023mc00449
In Re:
Third Party Subpoenas Ad Testificandum
Petitioner:
Sughrue Mion PLLCS
Respondent:
Novartis Pharmaceuticals Corporation
In Re: Third Party Subpoenas Ad Testificandum
as 1:2023mc00448
In Re:
Third Party Subpoenas Ad Testificandum
Petitioner:
Chidambaram S. Iyer
Respondent:
Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation et al v. MSN Pharmaceuticals Inc. et al
as 1:2023cv00550
Plaintiff:
Novartis Pharmaceuticals Corporation and Astex Therapeutics Ltd.
Defendant:
MSN Pharmaceuticals Inc. and MSN Laboratories Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Genzyme Corporation et al v. Novartis Gene Therapies, Inc. et al
as 1:2023cv00554
Plaintiff:
Genzyme Corporation and Aventis Inc.
Defendant:
Novartis Gene Therapies, Inc.
Counter Claimant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Novartis Pharmaceuticals Corporation v. Nanjing Noratech Pharmaceutical Co., Limited
as 1:2023cv00401
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Nanjing Noratech Pharmaceutical Co., Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al
as 1:2023cv00026
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
HEC Pharm Co., Ltd., HEC Pharm USA Inc., Sunshine Lake Pharma Co., Ltd. and others
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Ingenus Pharmaceuticals, LLC
as 1:2022cv01045
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Ingenus Pharmaceuticals, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
